1 Market Overview
1.1 Product Overview and Scope of Women Health Diagnostics
1.2 Classification of Women Health Diagnostics by Type
1.2.1 Overview: Global Women Health Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Women Health Diagnostics Revenue Market Share by Type in 2020
1.2.3 Prenatal Testing
1.2.4 Down Syndrome
1.2.5 HPV
1.2.6 Fertility Test
1.2.7 Pregnancy Test
1.2.8 Other
1.3 Global Women Health Diagnostics Market by Application
1.3.1 Overview: Global Women Health Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Home Care
1.4 Global Women Health Diagnostics Market Size & Forecast
1.5 Global Women Health Diagnostics Market Size and Forecast by Region
1.5.1 Global Women Health Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Women Health Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Women Health Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Women Health Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Women Health Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Women Health Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Women Health Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Women Health Diagnostics Market Drivers
1.6.2 Women Health Diagnostics Market Restraints
1.6.3 Women Health Diagnostics Trends Analysis
2 Company Profiles
2.1 Agilent Technologies, Inc.
2.1.1 Agilent Technologies, Inc. Details
2.1.2 Agilent Technologies, Inc. Major Business
2.1.3 Agilent Technologies, Inc. Women Health Diagnostics Product and Solutions
2.1.4 Agilent Technologies, Inc. Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.2 Ariosa Diagnostics, Inc
2.2.1 Ariosa Diagnostics, Inc Details
2.2.2 Ariosa Diagnostics, Inc Major Business
2.2.3 Ariosa Diagnostics, Inc Women Health Diagnostics Product and Solutions
2.2.4 Ariosa Diagnostics, Inc Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Ariosa Diagnostics, Inc Recent Developments and Future Plans
2.3 Bio-Rad Laboratories, Inc
2.3.1 Bio-Rad Laboratories, Inc Details
2.3.2 Bio-Rad Laboratories, Inc Major Business
2.3.3 Bio-Rad Laboratories, Inc Women Health Diagnostics Product and Solutions
2.3.4 Bio-Rad Laboratories, Inc Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bio-Rad Laboratories, Inc Recent Developments and Future Plans
2.4 Illumina, Inc
2.4.1 Illumina, Inc Details
2.4.2 Illumina, Inc Major Business
2.4.3 Illumina, Inc Women Health Diagnostics Product and Solutions
2.4.4 Illumina, Inc Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Illumina, Inc Recent Developments and Future Plans
2.5 Laboratory Corporation of America Holdings
2.5.1 Laboratory Corporation of America Holdings Details
2.5.2 Laboratory Corporation of America Holdings Major Business
2.5.3 Laboratory Corporation of America Holdings Women Health Diagnostics Product and Solutions
2.5.4 Laboratory Corporation of America Holdings Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.6 Natera, Inc
2.6.1 Natera, Inc Details
2.6.2 Natera, Inc Major Business
2.6.3 Natera, Inc Women Health Diagnostics Product and Solutions
2.6.4 Natera, Inc Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Natera, Inc Recent Developments and Future Plans
2.7 PerkinElmer, Inc
2.7.1 PerkinElmer, Inc Details
2.7.2 PerkinElmer, Inc Major Business
2.7.3 PerkinElmer, Inc Women Health Diagnostics Product and Solutions
2.7.4 PerkinElmer, Inc Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 PerkinElmer, Inc Recent Developments and Future Plans
2.8 Sequenom, Inc
2.8.1 Sequenom, Inc Details
2.8.2 Sequenom, Inc Major Business
2.8.3 Sequenom, Inc Women Health Diagnostics Product and Solutions
2.8.4 Sequenom, Inc Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sequenom, Inc Recent Developments and Future Plans
2.9 LifeCodexx
2.9.1 LifeCodexx Details
2.9.2 LifeCodexx Major Business
2.9.3 LifeCodexx Women Health Diagnostics Product and Solutions
2.9.4 LifeCodexx Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 LifeCodexx Recent Developments and Future Plans
2.10 Cenata
2.10.1 Cenata Details
2.10.2 Cenata Major Business
2.10.3 Cenata Women Health Diagnostics Product and Solutions
2.10.4 Cenata Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Cenata Recent Developments and Future Plans
2.11 Berrygenomics
2.11.1 Berrygenomics Details
2.11.2 Berrygenomics Major Business
2.11.3 Berrygenomics Women Health Diagnostics Product and Solutions
2.11.4 Berrygenomics Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Berrygenomics Recent Developments and Future Plans
2.12 BGI
2.12.1 BGI Details
2.12.2 BGI Major Business
2.12.3 BGI Women Health Diagnostics Product and Solutions
2.12.4 BGI Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 BGI Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Women Health Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Women Health Diagnostics Players Market Share
3.2.2 Top 10 Women Health Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Women Health Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Women Health Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Women Health Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Women Health Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Women Health Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Women Health Diagnostics Revenue by Type (2016-2026)
6.2 North America Women Health Diagnostics Revenue by Application (2016-2026)
6.3 North America Women Health Diagnostics Market Size by Country
6.3.1 North America Women Health Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Women Health Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Women Health Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Women Health Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Women Health Diagnostics Revenue by Type (2016-2026)
7.2 Europe Women Health Diagnostics Revenue by Application (2016-2026)
7.3 Europe Women Health Diagnostics Market Size by Country
7.3.1 Europe Women Health Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Women Health Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Women Health Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Women Health Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Women Health Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Women Health Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Women Health Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Women Health Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Women Health Diagnostics Market Size by Region
8.3.1 Asia-Pacific Women Health Diagnostics Revenue by Region (2016-2026)
8.3.2 China Women Health Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Women Health Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Women Health Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Women Health Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Women Health Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Women Health Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Women Health Diagnostics Revenue by Type (2016-2026)
9.2 South America Women Health Diagnostics Revenue by Application (2016-2026)
9.3 South America Women Health Diagnostics Market Size by Country
9.3.1 South America Women Health Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Women Health Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Women Health Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Women Health Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Women Health Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Women Health Diagnostics Market Size by Country
10.3.1 Middle East & Africa Women Health Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Women Health Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Women Health Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Women Health Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
【掲載企業】
Agilent Technologies, Inc.、Ariosa Diagnostics, Inc、Bio-Rad Laboratories, Inc、Illumina, Inc、Laboratory Corporation of America Holdings、Natera, Inc、PerkinElmer, Inc、Sequenom, Inc、LifeCodexx、Cenata、Berrygenomics、BGI
【免責事項】
https://www.globalresearch.jp/disclaimer